Our conclusion is similar to reports in children with BCR-ABL1 in whom IKZF1 deletion is associated with worse outcomes and with results of a recent meta-analysis indicating IKZF1 deletion is independently-associated with worse outcomes in children and adults with ALL [27, 28]. This evidence concerns the gene IKZF1 and acute lymphoblastic leukemia.